DCF — BAPTIST MEDICAL CENTER EAST
Enterprise Value: $-266.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-266.1M
Enterprise Value
$-84.5M
PV of Cash Flows
$-181.6M
PV of Terminal Value
$-292.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $174.6M | $-16.4M | -9.0% | $-23.8M | $-21.7M |
| Year 2 | $179.9M | $-15.1M | -8.0% | $-22.7M | $-18.8M |
| Year 3 | $185.3M | $-13.7M | -7.0% | $-21.6M | $-16.2M |
| Year 4 | $190.8M | $-13.2M | -7.0% | $-21.3M | $-14.5M |
| Year 5 | $196.5M | $-13.1M | -7.0% | $-21.4M | $-13.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-266.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$169.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09907538731360374
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5